Filtered by category: Performance Measurement Clear Filter

Convening to Advance MTM Service Quality Measurement

Registration has opened forPQA Convenes: Advancing Medication Therapy Management Quality Measurement,” which will take place on Thursday, November 2 in Arlington, Va. This invite-only event will bring together PQA members and industry experts to discuss the state of medication therapy management (MTM) practice, implications of recent Centers for Medicare & Medicaid Services (CMS)proposals and opportunities to evolve MTM quality measurement. 

Read More

PQA Seeks Pharmacy and Payer Partners for Adult Immunization Pilots

The Pharmacy Quality Alliance (PQA) seeks interested pharmacy and payer partners to participate in proof-of-concept pilots to implement and test high priority immunization pharmacy measure concepts.

Read More

Aiming for the Next Generation of MTM Quality Measures

PQA has launched the PQA Quality Innovation and Research Initiative to Advance Medication Therapy Management Quality Measurement – a national initiative to advance medication therapy management (MTM) quality measurement and other strategies to evaluate MTM services.

Read More

PQA Appoints 16 Individuals to Specialty Pharmacy Prescription Abandonment Rate TEP

PQA has appointed 16 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specifications for the pharmacy measure concept, Specialty Pharmacy Prescription Abandonment Rate [Pharmacy] (SP-AR-PH).

Read More

PQA Appoints 19 Individuals to Health Equity TEP

PQA has appointed 19 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on specific approaches to ensuring PQA’s measures support equitable health care.

Read More

PQA Sociodemographic Status Risk Adjustment FAQs

Health outcomes can be influenced by many factors other than the health care services received, including patient-related factors such as existing clinical conditions and sociodemographic status (SDS), which refers to a variety of socioeconomic (e.g., income, education, occupation) and demographic factors (e.g., age, race, ethnicity, primary language).  

Read More

PQA Measures in CMS Quality Programs

PQA uses a systematic, transparent, and consensus-based process to conceptualize, specify, test, and endorse quality measures. Following endorsement by PQA’s membership, PQA measures can be implemented into various quality programs, including those maintained by the Centers for Medicare & Medicaid Services (CMS). Many PQA measures are used in CMS Quality Programs to evaluate safe and appropriate medication use among beneficiaries.

Read More

PQA Appoints New Members to Serve on MUP and QMEP

PQA has appointed individuals from member organizations to serve on the 2023 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP).

Read More

Measure Retirement Process With Member Input

PQA follows a systematic, transparent, and consensus-based process in the development and maintenance of measures. This process ensures that PQA measures are relevant and continue to support improvement in health care.

Read More

PQA is Soliciting Feedback on Health Plan PDC Composite Measure

The Pharmacy Quality Alliance (PQA) has developed a new health plan performance measure focused on medication adherence, Proportion of Days Covered Composite (PDC-CMP). PQA is actively soliciting feedback on this measure via a public comment period which opened on October 3 and will close on October 24, 2022. Stakeholders are invited to provide comments  

Read More

PQA Appoints 15 Individuals to Serve on COPD Treatment Ratio TEP

PQA has appointed 15 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specification for a health plan performance measure concept: COPD (chronic obstructive pulmonary disease) Treatment Ratio (CTR). 

Read More

PQA Developing Health Plan Measure for COPD Treatment Ratio

PQA, the Pharmacy Quality Alliance, has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). 

Read More

Measure Stewardship with Expert Input and Consensus-Based Process

PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. However, the measurement lifecycle does not end when a measure is endorsed.  

Read More

Understanding PQA Measures

Quality measures are standards for measuring the performance of health care providers to care for patients and populations. PQA develops and stewards measures focused on medication use. 

Read More

Developing PQA Measures Through Public Comment and Endorsement

PQA follows a systematic, transparent and consensus-based developmentprocess to ensure that measures are important, scientifically acceptable, feasible and usable. This approach produces strong, consistent results, but it also takes time. 

Read More

PQA Appoints 17 Individuals to Serve on Health Plan PDC Composite Measure TEP

PQA has appointed 17 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specifications for a health plan measure concept: Proportion of Days Covered (PDC) Composite. 

Read More

Developing Measures with Expert Input and Comprehensive Testing

PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. This approach produces strong, consistent results, but it also takes time. 

Read More

PQA Publishes 2022 Measure Manual and Value Sets

PQA has published the 2022 PQA Measure Manual and Value Sets. The PQA Measure Manual includes detailed narrative specifications for PQA measures, which are needed to implement the measures accurately and appropriately. PQA Value Sets, which include National Drug Codes (NDCs), are required to calculate PQA measures as specified. 

Read More

PQA Seeks Pharmacy and Payer Partners for VBA Pilots

The Pharmacy Quality Alliance (PQA) seeks interested pharmacy and payer partners to participate in proof-of-concept pilots to implement high priority blood pressure and hemoglobin A1c measure concepts in value-based payment arrangements (VBAs). 

Read More

Adapting PQA’s Claims-Based Opioid Quality Measures to PDMP Data

Prescription opioid-related deaths are one of the leading preventable public health problems. High-risk prescribing practices have contributed to the opioid overdose epidemic. These include overlapping opioid and benzodiazepine prescriptions, prescribing high-dose opioids and using multiple prescribers or pharmacies for opioid prescriptions. 

Read More